Skip to content
‹ Back to IndustriesSciences

Ultramassive Black Hole Discovery Adds New Dimensions To Our Understanding of Space

Recent research from Durham University has uncovered a black hole so massive that it’s difficult to wrap our heads around. Weighing in at a staggering 30 billion times the size of our sun, this ultramassive black hole discovery has scientists questioning our current understanding of the cosmos. What are some of the most important…

This story was produced through MarketScale. See how Sciences teams put it to work with Executive Thought Leadership.

By Azam Saghir · · AstronomyBlack HoleBob RogersCosmic Discovery
Share

Key takeaways

01

Recent research from Durham University has uncovered a black hole so massive that it’s difficult to wrap our heads around.

02

Weighing in at a staggering 30 billion times the size of our sun, this ultramassive black hole discovery has scientists questioning our current understanding of the cosmos.

03

What are some of the most important…

Free workspace

Turn your Sciences expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

Recent research from Durham University has uncovered a black hole so massive that it’s difficult to wrap our heads around. Weighing in at a staggering 30 billion times the size of our sun, this ultramassive black hole discovery has scientists questioning our current understanding of the cosmos. What are some of the most important takeaways from this discover?

Astronomers at Durham University discovered this colossal black hole using a technique called gravitational lensing – a method involving the observation of how passing light is affected by the black hole’s intense gravitational pull. This breakthrough discovery, published in the journal Monthly Notices of the Royal Astronomical Society, is the first of its kind to utilize gravitational lensing to measure black holes. Experts like Nightingale, one of the chief researchers on this discovery, are left pondering how such a colossal black hole could even have formed in just 13 billion years since the universe’s birth.

On an innovative front, the application of gravitational lensing may open new possibilities for detecting black holes beyond our local universe, illuminating the evolution of these enigmatic phenomena over the course of cosmic history.

Intrigued by the similarities between digital twin methodology and the techniques used in this groundbreaking discovery, Bob Rogers, CEO of Oii.ai and a Ph.D. holder in Physics who has developed digital twins of supermassive black holes in other galaxies, dives deep into the research behind the discovery of this ultramassive black hole and the significance of this discovery on our understanding of the universe and its most explosive tendencies.

Bob’s Thoughts

“When I got my PHD back in the 90s, we were excited to learn that quasars and active galaxies had supermassive black holes at their centers. The newly discovered Abell 1021 BCG ultra massive black hole is estimated to be 10 to a hundred times larger – a whopping one-50th of the mass of our entire Milky Way galaxy and one of the top 10 largest black holes ever discovered.

It took some very special circumstances to create such a huge black hole. There are a few things to note here. First, unlike supermassive black holes that tend to be very bright sources of radio waves, x-rays and or gamma rays, this ultra-massive black hole was spotted because it caused the distortion of the light behind from a galaxy behind it. A phenomenon called microlensing. A great example is the bending of space-time caused by gravity. 

Second, a black hole this large was likely formed by the interaction of three separate galaxies, each of which had its own supermassive black hole. If we’ve spotted one of these, there’s going to be more, and so we might even be able to detect gravitational waves from some of them.

Finally, researchers used a digital twin methodology to infer the mass of the ultra-massive black hole that was causing the observed microlens. As an industrial practitioner of digital twins today, it’s exciting for me to see some of the same techniques we’re using in the supply chain being used in astronomy as well.”

Article written by Azam Saghir.

Your experts belong here

Every story in MarketScale Sciences starts with a company putting its lab directors, applications scientists, and field specialists on the record. Buyers are already reading this topic. The only question is whose experts they find.

Lab and research buyers verify before they trial, and your scientists give them something credible to verify against.

Book DemoSee how it works15 minutes, straight to a calendar.

About the author

AS
Azam Saghir
B2B Weekly

The week in Sciences, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Sciences: are you visible to AI?

Before they reach out, Sciences buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Sciences expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your lab directors, applications scientists, and field specialists into the articles, video, and social content Sciences buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Sciences Insights

Antibody developability checks are moving into discovery instead of waiting for development

Antibody developability checks are moving into discovery instead of waiting for development

Maria Gonzalez-Pajuelo of FairJourney Bio says the order in antibody discovery is changing: developability has become a much more important consideration during discovery, rather than an issue left until later-stage development. The goal, she says, is that what comes out of discovery is something CMC can take forward easily.

  • 01Discovery-stage developability screens can rank many antibodies tested once or twice and may reduce surprises later in development, while development still focuses on several lots of a single antibody and answers different questions.

Oct 1, 2026

Caraballo expects AI across all five tracks at ISPE’s 2026 Annual Meeting

Caraballo expects AI across all five tracks at ISPE’s 2026 Annual Meeting

ISPE’s 2026 Annual Meeting and Expo in Washington, DC organizes its program around five tracks running from discovery to governance, with international program committee chair Connie Langer of Pfizer Global Supply and executive chair Jose Caraballo of JCO Global Advisory LLC describing how the tracks connect—and why AI is treated as a cross-cutting topic rather than a standalone track. Deloitte’s December 2025 survey of 280 executives frames the mood the program is built for.

  • 01ISPE’s 2026 Annual Meeting has no dedicated AI track; executive chair Jose Caraballo expects AI presentations across all five tracks, from discovery to governance.
  • 02Deloitte’s December 2025 survey of 280 biopharma and medtech C-suite executives found more than 75% confident in their own outlook but only 41% optimistic about the global economy, a mood the story says the ISPE chairs are programming for.
  • 03A staffing firm reports life sciences job openings falling even as digital fluency becomes a required skill, so the upskilling burden lands on the people already employed, which is where the mandatory, university-partnered AI training Connie Langer describes at her company sits.

Sep 30, 2026

Crown Bioscience's San Diego site fits the tumor model to the therapy, not the reverse

Crown Bioscience's San Diego site fits the tumor model to the therapy, not the reverse

Crown Bioscience's San Diego site designs preclinical tumor models to match specific therapies and delivery routes, rather than forcing treatments into standard study designs. It combines custom surgical procedures, cell line-derived xenografts, patient-derived xenografts (including post-treatment models), and biomarker capabilities to generate translational data that can help sponsors decide whether to advance a program.

  • 01Orthotopic brain tumor implantation using tagged models lets researchers track tumor growth in the original organ, aligning the model and delivery route with how therapies are intended to be tested.
  • 02Patient-derived xenografts developed from tumors after prior treatment may better reflect progressed disease, helping teams study therapies aimed at patients whose cancer has advanced after earlier treatment.
  • 03Combining biomarker analysis of preclinical model samples with clinical sample testing at one site could make it easier to connect what is measured in animals with what is later measured in patients.

Sep 30, 2026

Explore More Sciences Insights

Read more expert perspectives from across Sciences.

Browse Sciences Hub

About the Expert

AS
Azam Saghir

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Sciences and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512